LIMG
LIMITATION OF GOODS RECEIVED FROM IB
03/19/2026
Back to search
Official data from USPTO
CCRM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CCRM
ST13
US500000079338771Class
35, 40, 42, 45
Filing
79338771
Registration
7226858
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/20/2026
Classification
Registered
Trademark type
Word
Nice classes
35, 40, 42, 45
Filing date
11/19/2021
Registration date
11/28/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/28/2023
Last transaction
03/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
54
Owner location
CA
Examiner
FOSDICK, GEOFFREY A
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. M. (pessoa física)
Representatives
David J. Davis Baker & McKenzie LLP
Technical classification
Nice Classes
Class 35Class 40Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business planning; providing market intelligence services
Class 40
Custom manufacture of biotechnological products for therapeutic use in the diagnosistreatmentmitigation or prevention of diseasedisorder or abnormal physical state or their symptoms
Class 42
Development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development of new biotechnological products for others for therapeutic use in the diagnosistreatmentmitigation or prevention of diseasedisorder or abnormal physical state or their symptoms; development of new biotechnological products for others for therapeutic use in the diagnosistreatmentmitigation or prevention of diseasedisorder or abnormal physical state or their symptoms; providing medical and scientific research information in the field of clinical trials; medical and scientific researchconducting clinical trials for others; genetic testing for scientific research purposes in the field of biotechnological products for therapeutic use in the diagnosistreatmentmitigation or prevention of diseasedisorder or abnormal physical state or their symptoms; scientific research in the field of genetic engineeringresearch of biotechnological products for therapeutic use in the diagnosistreatmentmitigation or prevention of diseasedisorder or abnormal physical state or their symptoms
Class 45
Reviewing standards and practices to assure compliance with regulations related to the researchdevelopmentmanufacture and sale of products in the health care and medical fields and the administration of health care services
Publications
History of USPTO decisions and trademark events.
31 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/08/2024
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/02/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
03/02/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/28/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/28/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/28/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/16/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/27/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/27/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/12/2023
PUBO
PUBLISHED FOR OPPOSITION
09/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/23/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/23/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/23/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2023
DOCK
ASSIGNED TO EXAMINER
07/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2023
RFNT
REFUSAL PROCESSED BY IB
01/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/09/2022
RFRR
REFUSAL PROCESSED BY MPU
12/09/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/28/2022
CNRT
NON-FINAL ACTION WRITTEN
09/27/2022
DOCK
ASSIGNED TO EXAMINER
08/31/2022
MAFR
APPLICATION FILING RECEIPT MAILED
04/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/22/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/21/2022
Continuous trademark protection
Get notified about every new filing that threatens CCRM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.